The Role of Donor Lymphocyte Infusion (DLI) in Post Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
暂无分享，去创建一个
R. Vij | M. Aljurf | J. Szer | B. George | U. Popat | J. Cerny | H. Lazarus | Y. Liu | D. Weisdorf | R. Sobecks | N. Chaudhri | B. Wirk | U. Gergis | R. Kamble | R. Olsson | S. Seo | W. Saber | P. Wiernik | J. H. Holter Chakrabarty | R. Herzig | G. Hildebrandt | H. Abdel-Azim | M. Kharfan-Dabaja | B. Scott | E. Alyea | Zhen-Huan Hu | Vaibhav Agrawal | U. Bacher | S. Nathan | T. Nishihori | K. Williams | J. Hsu | N. Farhadfar | D. Maharaj | G. Ortí | S. Schmidt | J. Černý | Zhen-Huan Hu